<DOC>
	<DOCNO>NCT02942927</DOCNO>
	<brief_summary>In age population , senior suffer multiple chronic condition . When number medication take ≥5 ( polypharmacy ) , burden take multiple concurrent medication harm good . Seniors take average 7 regular medication study link polypharmacy adverse effect morbidity , function health service use . However , clear extent reversible medication burden reduce . This trial test effect medication number patient health outcome intervention polypharmacy . This study test program focus medication reduction number dose . Prioritizing medication accord patient 's preference reducing dose also reduce risk drug side effect . Patients , age 69 year take ≥5 medication , randomly receive program immediately 6 month . The program involve information gathering patient , include systematically seek patient priority preference medication review pharmacist consultation family doctor . The intervention focus discontinuing/reducing dose medication possible use 'pause monitor ' framework ass need restart . An electronic program detects drug adverse effect flag potentially inappropriate medication integrate electronic clinical pathway incorporate monitor follow system . This study examine effect patient health relevant outcome measure well qualitative research explore patient ' clinician ' experience reduce medication burden . The result use determine whether system implement part routine preventative care primary care older adult .</brief_summary>
	<brief_title>Team Approach Polypharmacy Evaluation Reduction</brief_title>
	<detailed_description>Patients randomize 1:1 receive intervention study start delay appointment 6 month later . Initial baseline data collection patient include data demographic , medication , illness characteristic . The patient attend appointment pharmacist review medication appropriate discontinuation/dose reduction , patient meet his/her family physician discus patient preference discontinuation/dose reduction . Both health care provider access TAPERMD , web base program link evidence tool support reduction polypharamcy . Follow research assessment take place one week , 3 month 6 month ( study end ) . Outcome assessment semi-structured interview take place 6 month appointment .</detailed_description>
	<criteria>Aged 70 year age old Patient must family doctor Participating family doctor responsible provider Currently take 5 long term medication Have recent comprehensive medication review Patient willing try discontinuation English language cognitive skill inadequate understand respond rating scale Terminal illness circumstance preclude 6 month study period</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Polypharmacy</keyword>
	<keyword>Multimorbidity</keyword>
	<keyword>Randomized Control Trial</keyword>
	<keyword>Drug Discontinuation</keyword>
	<keyword>Patient Preference</keyword>
	<keyword>eHealth</keyword>
</DOC>